Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05139303 · ClinicalTrials.gov registry record · NA
Efficacy of the OrthoApnea NOA® Mandibular Advancement Device in the Management of Obstructive Sleep Apnea.
A NA study, sponsored by Isabel Moreno Hay.
- Completed
- Registry status
- NA
- Development phase
- 37
- Enrollment target
NCT05139303 is a NA study that has completed, run by Isabel Moreno Hay. The registered enrollment target is 37 participants.
The verdict
NCT05139303, a NA study, has completed, sponsored by Isabel Moreno Hay.
- COMPLETED
- Registry status
- NA
- Development phase
- 37 participants
- Enrollment target
Study Summary
The objective of this study is to assess the efficacy of the Orthoapnea NOA® mandibular advancement device and describe the percentage of advancement (%) needed to reach efficacy, and to retrospectively compare with other MAD designs in the management of obstructive sleep apnea. Additionally, to describe patient compliance and adherence to the therapy with the Orthoapnea NOA® device, and to assess the incidence and prevalence of signs, symptoms, and diagnosis of temporomandibular disorders (TMD) associated to the use of the Orthoapnea NOA® mandibular advancement device.
Interventions
- DEVICE Orthoapnea NOA®
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 37 participants |
| Start Date | 2021-11-15 |
| Est. Completion | 2023-08-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05139303
The ClinicalTrials.gov registry entry for NCT05139303 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 37 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Isabel Moreno Hay, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Orthoapnea NOA® is the first listed.
NCT05139303 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05139303 about?
NCT05139303 is a clinical study titled "Efficacy of the OrthoApnea NOA® Mandibular Advancement Device in the Management of Obstructive Sleep Apnea.". The objective of this study is to assess the efficacy of the Orthoapnea NOA® mandibular advancement device and describe the percentage of advancement (%) needed to reach efficacy, and to retrospectively compare with other MAD designs in the management of obstructive sleep apnea. Additionally, to des...
What is the current status of trial NCT05139303?
This trial is currently completed. It is a NA study. The enrollment target is 37 participants. The study started on 2021-11-15. Estimated completion is 2023-08-02.
What interventions are being tested in trial NCT05139303?
The interventions under investigation include: Orthoapnea NOA® (DEVICE).
Who is sponsoring clinical trial NCT05139303?
This trial is sponsored by Isabel Moreno Hay, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.